ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 750039 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 750039; 2) Community: the network communities that were significantly associated with the response to NSC 750039; 3) Molecule: the relationships between components within communities and NSC 750039; 4) MDR: the compounds that were significantly associated with the NSC 750039.

NSC Compound Enrichment Correlation
NSC 36525 8-[(4-tert-butylphenoxy)methyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione 0.000649370174092101 0.37490195
NSC 377852 Null 0.000649370174092101 0.37363191
NSC 50648 Null 0.000649370174092101 0.26348337
NSC 648154 Null 0.000649370174092101 0.18547849
NSC 676345 Pyrimidine-2,4-diamine, 6-chloro-N(4)- [[1-(hydroxymethyl)-3-(2-phenylethyl)cyclobutyl]methyl]- 0.000649370174092101 0.59743889
NSC 684409 18-Norestr-4-en-3-one, 17-ethynyl-13-ethyl- 17.beta.-hydroxy-,2-[(9,10-dihydro-10-oxo-4-acridinyl)carbonyl]hydrazone 0.000649370174092101 0.23609743
NSC 6926 Null 0.000649370174092101 0.20789531
NSC 703784 L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride 0.000649370174092101 0.16341429
NSC 753456 2-4-[5-(3,5-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,6,7-trimethoxy-1,3-benzothiazole 0.000649370174092106 0.54579785
NSC 357777 Null 0.000710545569439728 0.21035655
Total:102  Current:4    [First] [Prev] [Next] [Last]